Partnerships clinical trials 2010

Actelion senior manager for global competitive intelligence Dr Yulia Aspinall says the general economic backdrop and the mega mergers witnessed this year have, and are still, defining the pharmaceutical landscape. When resources are scarce and patents fast expiring, effective competitive intelligence is paramount to ensuring the success of pharmaceutical firms. The fact that courtship was en vogue was suitably confirmed.

Falling drug prices and competition from generic makers cashing in on the loss of patents on blockbuster drugs were all factors in these deals which, according to Aspinall, are unlikely to stop.

As big pharma wakes up to the need to enter the biologics market and mergers gain pace in this space, Aspinall says competitive intelligence will need to play a vital role. For mainstream society the H1N1 influenza outbreak was a cause of somewhat serious concern.

As of 4 December there have been 8, confirmed swine flu deaths worldwide — a sizeable number but a far cry from the one million killed in the Hong Kong flu in It has been enough, however, to raise near hysteria among the public and for governments to pledge millions of dollars in the direction of the first effective antivirals out the door.

Biopharma Conferences. Therapy Conferences. Therapies Conferences. Antibiotics Conferences. Medical Equipment Conferences. Armamentarium Conferences. Instruments Conferences. Infusions Conferences. Tongue Depressors Conferences. Pacemakers Conferences. Inhalers Conferences. Injectors Conferences. Biomedical Conferences. Telemedicine Conferences. Medtech Conferences. Nanomedicine Conferences.

Digital Health Conferences. Neurotech Conferences. Neurotechnology Conferences. Personalized Medicine Conferences. Individualized Medicine Conferences. Robotic Surgery Conferences. Robotic Assisted Surgery Conferences. Clinical Conferences.

Biochemical Pharmacology Conferences. Biomedical Imaging Conferences. Clinical Applications Conferences. Obama's administration must recognize the important of the Medicare clinical trial policy to ensure that Medicare beneficiaries are covered.

It will be interesting to see if the new administration will soon address this policy and take action. Posted by Thiago at PM No comments:. Labels: Clinical trials , clinical trials partnerships , Medicare , Obama , obama administration. Wednesday, August 19, Stem cells for the heart in clinical trial.

The US News and World Report recently looked at a clinical trail taking place in the western United States which takes stem cells from ones body, treats them, and then injects them back into unhealthy hearts. This study is hoping to find a way to help heart failure patients rejuvenate their heart with their own stem cells. Read more about the trial here. Posted by Unknown at AM No comments:. Monday, August 17, Biopharma in India is Surging. According to this article in FierceBiotech a weakened economy and the need for cutbacks is pushing big pharma companies to drive drug development and manufacturing in India.

One thing though, many Indian developers are having a hard time transitioning from manufacturing generic drugs to devising new therapies. This is certainly a huge opportunity for Indian firms to thrive if they can ease the transition somehow. It will be interesting to see how things will play out over the course of the next couple of years.

Enter your email address to comment. Enter your website URL optional. Jeff Schneebaum. Director of Operations, Ophthalmology.

Jason Slakter, M. Medical Director. Rona Osmani.